Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 19/20 | 0.55 |
| ▸ | CAPNS1 | P04632 | 5/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGAV | P06756 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8404260 | 1.00 | CAPN1 (0.55) | CAPN1CAPNS1ITGB3ITGAV | |
| SCHEMBL8810462 | 0.94 | CAPN1 (0.48) | CAPN1CAPNS1ITGB3ITGAV | |
| SCHEMBL8810452 | 0.94 | CAPN1 (0.48) | CAPN1CAPNS1ITGB3ITGAV | |
| SCHEMBL8407600 | 0.86 | CAPN1 (0.49) | CAPN1CAPNS1ITGB3ITGAV | |
| SCHEMBL8407608 | 0.86 | CAPN1 (0.49) | CAPN1CAPNS1ITGB3ITGAV | |
| SCHEMBL8807405 | 0.84 | CAPN1 (0.63) | CAPN1 | |
| SCHEMBL8807417 | 0.84 | CAPN1 (0.63) | CAPN1 | |
| SCHEMBL8808352 | 0.81 | CAPN1 (0.62) | CAPN1CAPNS1 | |
| SCHEMBL8808370 | 0.81 | CAPN1 (0.62) | CAPN1CAPNS1 | |
| SCHEMBL8404262 | 0.81 | NR3C1 (0.43) | CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925786-A1 | REMEDIES FOR ISCHEMIC DISEASES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-06-30 | — | — | EP | claimed |
| EP-0925786-A1 | REMEDIES FOR ISCHEMIC DISEASES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-06-30 | — | — | EP | disclosed |
| EP-0810221-A1 | OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-12-03 | — | — | EP | disclosed |